Screener
Wave Life Sciences WVE Free cash flow
Free cash flow at other companies
Other financials
Where this comes from
Calculated from Wave Life Sciences’s reported figures.
The source filing: Wave Life Sciences’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 7:50 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-324949
FAQ
- What is Wave Life Sciences's free cash flow?
- Wave Life Sciences (WVE) reported free cash flow of -$54.47M in Q2 2026.
- How has Wave Life Sciences's free cash flow changed year-over-year?
- Wave Life Sciences's free cash flow decreased by 17.6% year-over-year, from -$46.32M to -$54.47M.
- What is the long-term trend for Wave Life Sciences's free cash flow?
- Over 3 years (2021 to 2025), Wave Life Sciences's free cash flow has grown at a 28.1% compound annual growth rate (CAGR), from -$89.55M to -$188.21M.
- What does free cash flow mean?
- Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.
Ask your AI about Wave Life Sciences's free cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude